|
HPV genotype
|
Odds ratio
|
95 % CI
|
P value*
|
|---|
|
CD4 count < 200 cells/μl
|
|
HPV 16
|
0.7
|
0.2–1.9
|
0.4
|
|
HPV 18
|
1.3
|
0.4–4.6
|
0.7
|
|
HPV 31
|
1.1
|
0.3–4.4
|
0.9
|
|
HPV 33
|
3.3
|
0.9–11.9
|
0.07
|
|
HPV 35
|
2.4
|
0.7–8.3
|
0.2
|
|
HPV 45
|
3.3
|
0.3–39.4
|
0.4
|
|
HPV 51
|
1.5
|
0.4–5.6
|
0.6
|
|
HPV 52
|
2.5
|
0.8 8.1
|
0.1
|
|
HPV 53
|
4.4
|
1.4–13.6
|
0.01
|
|
HPV 56
|
0.6
|
0.2–2.2
|
0.4
|
|
HPV 58
|
2.6
|
0.7–8.7
|
0.1
|
|
HPV 66
|
3.1
|
0.8–11.9
|
0.1
|
|
HPV 68
|
0.6
|
0.06–6.2
|
0.7
|
|
Multiple HPV co-infection
|
3.7
|
1.2–12.1
|
0.03
|
|
CD4 count ≥350 cells/μl
|
|
HPV 16
|
2.9
|
1.0–8.3
|
0.05
|
|
HPV 18
|
0.4
|
0.08–1.9
|
0.2
|
|
HPV 53
|
0.6
|
0.2–2.1
|
0.4
|
|
Multiple HPV co-infection
|
0.7
|
0.3–2.0
|
0.5
|
|
Age ≥ 30 adjusted for sexual partners
|
|
HPV 16
|
1.1
|
0.3–4.1
|
0.8
|
|
HPV 18
|
2.3
|
0.5–11.5
|
0.3
|
|
HPV 53
|
0.9
|
0.2–3.2
|
0.8
|
|
Multiple pHR/HR HPV infections
|
2.4
|
0.7–8.9
|
0.2
|
